B

Bregua

Europe, Castilla-La Mancha, Spain, Tórtola

Description

Bregua primarily operates as a venture capital firm.

Investor Profile

Bregua has made 8 investments, with 2 in the past 12 months and 13% as lead.

Stage Focus

  • Series A (50%)
  • Series B (25%)
  • Series C (13%)
  • Seed (13%)

Country Focus

  • United States (88%)
  • Germany (13%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Health Diagnostics
  • Pharmaceutical
  • Oncology
  • Life Science
  • Real Time
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bregua frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 2
Avalon Ventures
North America, California, United States, La Jolla
Co-Investments: 6
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Correlation Ventures
North America, California, United States, San Diego
Co-Investments: 2
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by Bregua?

Valora Therapeutics

La Jolla, California, United States

Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .

BiopharmaBiotechnologyClinical Trials
SeedNov 20, 2024
Amount Raised: $30,000,000
Enlaza Therapeutics

La Jolla, California, United States

Enlaza Therapeutics is a biotechnology research company.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AApr 30, 2024
Amount Raised: $100,000,000
Janux Therapeutics

La Jolla, California, United States

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics
Series BApr 20, 2021
Amount Raised: $125,000,000
Fortis Therapeutics

La Jolla, California, United States

Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies against CD46.

BiotechnologyOncologyTherapeutics
Series AMar 29, 2021
Amount Raised: $40,000,000
Janux Therapeutics

La Jolla, California, United States

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics
Series AMar 3, 2021
Amount Raised: $56,000,000
Acousia Therapeutics

Tübingen, Baden-Wurttemberg, Germany

Acousia Therapeutics is a privately held biotech company.

BiotechnologyHealth CareTherapeutics
Series BMay 14, 2018
Amount Raised: $11,931,252
Fortis Therapeutics

La Jolla, California, United States

Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies against CD46.

BiotechnologyOncologyTherapeutics
Series ASep 27, 2016
Amount Raised: $18,000,000
Avelas Biosciences

La Jolla, California, United States

Avelas Biosciences develops real-time luminous maps for oncologic surgeons to refer while in surgery.

BiotechnologyLife ScienceReal Time
Series CAug 18, 2016
Amount Raised: $20,000,000